Literature DB >> 34165688

New benzamide derivatives and their nicotinamide/cinnamamide analogs as cholinesterase inhibitors.

Mehmet Koca1, Sinan Bilginer2.   

Abstract

In this study, a total of 18 new benzamide/ nicotinamide/ cinnamamide derivative compounds were designed and synthesized for the first time (except B1 and B5) by conventional and microwave irradiation methods. The chemical structures of the synthesized compounds were characterized by 1H NMR, 13C NMR, and HRMS spectra. In vitro acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition effects of the compounds were evaluated to find out new possible drug candidate molecule/s. According to the inhibition results, the IC50 values of the compounds synthesized were in the range of 10.66-83.03 nM towards AChE, while they were in the range of 32.74-66.68 nM towards BuChE. Tacrine was used as the reference drug and its IC50 values were 20.85 nM and 15.66 nM towards AChE and BuChE, respectively. The most active compounds B4 (IC50: 15.42 nM), N4 (IC50: 12.14 nM), and C4 (IC50: 10.67 nM) in each series towards AChE were docked at the binding site of AChE enzyme to explain the inhibitory activities of each series. On the other hand, the compounds B4, N4, and C4 showed satisfactory pharmacokinetic properties via the prediction of ADME profiles.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Benzamide; Cholinesterase inhibition; Cinnamamide; Molecular docking; Nicotinamide

Mesh:

Substances:

Year:  2021        PMID: 34165688     DOI: 10.1007/s11030-021-10249-9

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  38 in total

Review 1.  Natural cholinesterase inhibitors from marine organisms.

Authors:  Lindon W K Moodie; Kristina Sepčić; Tom Turk; Robert FrangeŽ; Johan Svenson
Journal:  Nat Prod Rep       Date:  2019-03-29       Impact factor: 13.423

Review 2.  Effects of Alzheimer Disease on Patients and Their Family.

Authors:  Barbara J Grabher
Journal:  J Nucl Med Technol       Date:  2018-08-23

Review 3.  Myasthenia gravis.

Authors:  Nils Erik Gilhus; Socrates Tzartos; Amelia Evoli; Jacqueline Palace; Ted M Burns; Jan J G M Verschuuren
Journal:  Nat Rev Dis Primers       Date:  2019-05-02       Impact factor: 52.329

4.  Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer's disease.

Authors:  Hanan M Ragab; Mohamed Teleb; Hassan R Haidar; Noha Gouda
Journal:  Bioorg Chem       Date:  2019-02-14       Impact factor: 5.275

5.  Microwave-Assisted Organic Synthesis, structure-activity relationship, kinetics and molecular docking studies of non-cytotoxic benzamide derivatives as selective butyrylcholinesterase inhibitors.

Authors:  Sheeba Wajid; Asma Khatoon; Maria Aqeel Khan; Humaira Zafar; Shama Kanwal; M Iqbal Choudhary; Fatima Z Basha
Journal:  Bioorg Med Chem       Date:  2019-07-11       Impact factor: 3.641

6.  Antiallergic and cytoprotective activity of new N-phenylbenzamido acid derivatives.

Authors:  F Makovec; W Peris; L Revel; R Giovanetti; D Redaelli; L C Rovati
Journal:  J Med Chem       Date:  1992-10-02       Impact factor: 7.446

7.  Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.

Authors:  Ezio Giacobini; R Spiegel; A Enz; A E Veroff; N R Cutler
Journal:  J Neural Transm (Vienna)       Date:  2002-07       Impact factor: 3.575

8.  Amino-Substituted Benzamide Derivatives as Promising Antioxidant Agents: A Combined Experimental and Computational Study.

Authors:  Nataša Perin; Petra Roškarić; Irena Sović; Ida Boček; Kristina Starčević; Marijana Hranjec; Robert Vianello
Journal:  Chem Res Toxicol       Date:  2018-08-27       Impact factor: 3.739

Review 9.  History and progress of hypotheses and clinical trials for Alzheimer's disease.

Authors:  Pei-Pei Liu; Yi Xie; Xiao-Yan Meng; Jian-Sheng Kang
Journal:  Signal Transduct Target Ther       Date:  2019-08-23

10.  Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health.

Authors:  Paul Bentley; Jon Driver; Ray J Dolan
Journal:  Brain       Date:  2007-12-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.